Alcyone Lifesciences to Present at Piper Jaffray 31st Annual Healthcare Conference

Monday, December 2, 2019 Press Release
Email Print This Page Comment bookmark
Font : A-A+

LOWELL, Mass., Dec. 2, 2019 /PRNewswire/ -- Alcyone Lifesciences, Inc., a biotechnology company dedicated to precision administered genetic therapies to treat complex neurological and oncological conditions through the company's proprietary advanced precision administration platforms, today announced that Chief Executive Officer, PJ Anand, will present at the Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019 at 12:10 p.m. ET in New York, NY.

About Alcyone Lifesciences, IncAlcyone Lifesciences, Inc., based in Lowell, Massachusetts, is a privately-held biotechnology company dedicated to precision administered genetic therapies to treat complex neurological and oncological conditions through the company's proprietary advanced precision administration platform. For more information, please visit www.alcyonels.com

Contact Information: PJ AnandChief Executive Officerpjanand@alcyonels.com Phone: 978.709.1946

 

Cision View original content:http://www.prnewswire.com/news-releases/alcyone-lifesciences-to-present-at-piper-jaffray-31st-annual-healthcare-conference-300967214.html

SOURCE Alcyone Lifesciences, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store